Developing targeted technologies to improve efficiency of new as well as old drugs that are prescribed to treat neurological disorders and cancers. with the approval by the FDA the first nano-enabled drug delivery took place in 1995, there has been spurring growth in the market of nano enabled chemotherapy for cancer. Many of the nano-pharmacology products in market and several under clinical trials. Nano-pharmacology is a branch of pharmacology which investigates interaction of a nanomedicine with living systems area at the nanoscale level. Medicine which is modern is increases and concerned with various surface modified nano carriers, such as dendrimers, nanoparticles, carbon based nanomaterials, polymer-drug nanoconjugates, etc., which is  having immense therapeutic potential by having a  specific target of drug delivery,  By using nano scaffolding and nanocontainers, owing to the specific physical, chemical and biological properties of these moieties and is related to their nanoscale size range. Nano-pharmacology could have medical and pharmaceutical benefits and applications of nanotechnology in the delivery of therapeutic and diagnostic agents. Nanomaterials application in the cardiovascular has an huge importance, as well as, renal arena, in the near future.